From prescription-only to over-the-counter medicines ('PoM to P'): Time for an intermediate category

British Medical Bulletin

Volumn 90, Issue 1, 2009, Pages 63-69

  Aronson, Jeffrey K ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Over the counter medicines; Pharmacy only medicines; Prescription only medicines; Sildenafil; Simvastatin; Viagra

Indexed keywords

AMFEBUTAMONE; ANTIINFECTIVE AGENT; APOMORPHINE; ASTEMIZOLE; AZITHROMYCIN; DRUG; FINASTERIDE; LEVONORGESTREL; NON PRESCRIPTION DRUG; OMEPRAZOLE; PHENTERMINE; PRESCRIPTION DRUG; RANITIDINE; SCOPOLAMINE BUTYL BROMIDE; SIBUTRAMINE; SILDENAFIL; SIMVASTATIN; TERFENADINE; TETRAHYDROLIPSTATIN; UNCLASSIFIED DRUG; ZANAMIVIR; PHOSPHODIESTERASE INHIBITOR; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SULFONE;

ALOPECIA; CARDIOVASCULAR DISEASE; CHLAMYDIASIS; CONTRACEPTION; DRUG BIOAVAILABILITY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG SURVEILLANCE PROGRAM; ERECTILE DYSFUNCTION; GASTROESOPHAGEAL REFLUX; GRAPEFRUIT JUICE; HEALTH PROMOTION; HEARTBURN; HUMAN; INFLUENZA; INTERNET; IRRITABLE COLON; LAW; LONG TERM CARE; OBESITY; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QT PROLONGATION; REVIEW; TORSADE DES POINTES; ARTICLE; DRUG LEGISLATION; FEMALE; MALE; ORGANIZATION AND MANAGEMENT; PHARMACY; PRESCRIPTION; SELF MEDICATION; UNITED KINGDOM;

COMMUNITY PHARMACY SERVICES; DRUG PRESCRIPTIONS; ERECTILE DYSFUNCTION; FEMALE; GREAT BRITAIN; HUMANS; LEGISLATION, DRUG; MALE; NONPRESCRIPTION DRUGS; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINES; SELF MEDICATION; SULFONES;

EID: 70349572802     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldp015     Document Type: Review

References (25)

1. Speech by Jane Kennedy MP, Minister of State for Quality and Patient Safety, 23 November 2005. Self care and regulatory issues for the association of the European self-medication industry (AESGP) meeting. Available from http://www.dh.gov.uk/en/News/Speeches/ Speecheslist/DH-4123777 (accessed 9 February 2009).
2. Dhippayom T, Walker R (2006) Impact of the reclassification of omeprazole on the prescribing and sales of ulcer healing drugs. Pharm World Sci, 28, 194-198.
3. Aronson JK (2004) Over-the-counter medicines. Br J Clin Pharmacol, 58, 231-234.
4. Department of Health. Wider availability of emergency contraception. Available from http:// www.dh.gov.uk/en/Healthcare/Medicinespharmacyandindustry/ Prescriptions/DH-4049266 (accessed 9 February, 2009).
5. Medicines and Healthcare products Regulatory Agency. Legal status and reclassification. Available from: http://www.mhra.gov.uk/Howweregulate/ Medicines/Licensingofmedicines/ Legalstatusandreclassification/index.htm (accessed 9 February, 2009).
6. Fenichel RR (2004) Which drugs should be available over the counter? Br Med J 329, 182-183.
7. Ferner RE, Beard K (2008) Over the counter medicines: proceed with caution. Br Med J, 336, 694-696.
8. Committee on Safety of Medicines, Medicines Control Agency (1997) Terfenadine: now only available on prescription. Curr Probl Pharmacovig 23, 9.
9. Committee on Safety of Medicines, Medicines Control Agency (1999) Astemizole (Hismanal): only available on prescription. Curr Probl Pharmacovig 25, 2.
10. Aronson JK (2001). Forbidden fruit. Nature Med, 7, 7-8.
11. Levonorgestrel. British National Formulary, Number 57. London: BMJ Group/RPS Publishing, March 2009, 449.
12. Rubin N, Wylie K (2009) Should sildenafil be available over the counter? Br Med Bull (in press).
13. Loe M (2004) The Rise of Viagra. How the Little Blue Pill Changed Sex in America. NY and London: New York University Press, 177.
14. House of Commons Committee of Public Accounts. Safety, quality, efficacy: regulating medicines in the UK. Twenty-sixth Report of Session 2002-2003. Available from http:// www.parliament.the-stationery-office.com/pa/cm200203/ cmselect/cmpubacc/505/505.pdf (accessed 9 February 2009).
15. Boehringer Ingelheim. Buscopan IBS Relief-Summary of Product Characteristics. Available from http://emc.medicines.org.uk/document.aspx? documentId=15745 (accessed 9 February 2009).
16. Ford AC, Talley NJ, Spiegel BM et al. (2008) Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. Br Med J, 337, a2313.
17. Kostopoulou O, Devereaux-Walsh C, Delaney BC (2009) Missing celiac disease in family medicine: the importance of hypothesis generation. Med Decis Making April 10, 2009 [Epub ahead of print].
18. Emmerton L (2009) The 'third class' of medications: sales and purchasing behavior are associated with pharmacist only and pharmacy medicine classifications in Australia. J Am Pharm Assoc, (2003), 49, 31-37.
19. Norris PT (2002) Purchasing restricted medicines in New Zealand pharmacies: results from a 'mystery shopper' study. Pharm World Sci, 24, 149-153.
20. Hitchen L (2008) Switching antibiotics to pharmacy sale will increase resistance, doctors say. Br Med J, 337, a1538.
21. Royal Pharmaceutical Society of Great Britain. News Release, 6 November 2008. Society publishes azithromycin guidance. Available from http://www.rpsgb.org/pdfs/pr081106.pdf (accessed 9 February 2009).
22. Wald NJ, Law MR (2003) A strategy to reduce cardiovascular disease by more than 80%. Br Med J, 326, 1419.
23. Aronson JK (2004) Live long and prosper: a mass strategy for treating the factors associated with ischaemic heart disease and stroke. J Med Screen, 11, 1-2.
24. Marston C, Meltzer H, Majeed A (2005) Impact on contraceptive practice of making emergency hormonal contraception available over the counter in Great Britain: repeated cross sectional surveys. Br Med J, 331, 271.
25. Anonymous (2007) Boots launches private PGD service to supply Viagra. Pharm J, 278, 179.